Cite
HARVARD Citation
Yao, J. et al. (2021). Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms. Endocrine-related cancer. 28 (3), pp. 161-172. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yao, J. et al. (2021). Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms. Endocrine-related cancer. 28 (3), pp. 161-172. [Online].